Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8393-8406
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8393
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8393
Outcomes | ALD | NAFLD | Ref. |
Hepatocarcinogenesis | |||
Incidence rate | |||
Simple hepatic steatosis/steatohepatitis | 0%-0.2% per year | [115] | |
Steatohepatitis/cirrhosis | 0.3%-4.3% per year | [115] | |
Compensated cirrhosis | 0.7% per year | [90] | |
Decompensated cirrhosis | 1.4% per year | [91] | |
Compensated/decompensated cirrhosis | 2.5% per year | 2.1% per year | [96] |
Unknown stage | 0.043% per year | [95] | |
Prevalence rate of non-cirrhotic liver as underlying liver disease | 5.3%-12.0% | 25.0%-58.3% | [116-118] |
Comparison of survival | Similar to non-ALD, NBNC HCC | Better than ALD- or HCV-related HCC | [119,120] |
Hepatic decompensation | |||
Incidence rate | |||
Compensated cirrhosis | 4.4% per year | 4.5% per year | [90,121] |
Mortality (overall) | |||
Incidence rate | |||
Simple hepatic steatosis | 3.3% per year | [52] | |
Steatohepatitis | 5.0% per year | [52] | |
Steatohepatitis/cirrhosis | 1.8% per year | [100] | |
Compensated cirrhosis | 3.2% per year | [90] | |
Decompensated cirrhosis | 5.7%-6.0% per year | [91,97] | |
Compensated/decompensated cirrhosis | 5.0% per year | [124] | |
Compared with liver diseases due to other causes | Similar to HCV-related compensated liver disease | [100] | |
Similar to HCV-related compensated cirrhosis | Better than HCV-related compensated cirrhosis | [90,122] | |
Similar to HCV-related decompensated cirrhosis | Similar to HCV-related decompensated cirrhosis | [91,122] | |
Similar to HCV-related cirrhosis | [124] | ||
Improved survival | Abstinence | [123] | |
Causes of death | |||
Simple hepatic steatosis | [55] | ||
Liver-related causes | 17% | 2% | |
Arteriosclerosis | 20% | 38% | |
Extrahepatic malignancy | 14% | 17% | |
Infection | 3% | 8% | |
Cirrhosis | [90,97,98,122,124] | ||
HCC | 10%-13% | 6.9%-47.4% | |
Liver failure | 25%-60% | 17.2%-31.6% | |
Cardiovascular disease | 1% | 27.6% | |
Cerebrovascular disease | 1%-4% | ||
Infection | 8.9%-25% | 41.4% | |
Extrahepatic malignancy | 8%-25% |
- Citation: Toshikuni N, Tsutsumi M, Arisawa T. Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8393-8406
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8393.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8393